pharmaphorum

MARCH 16, 2021

SpectronRx , a leading radiopharmaceutical contract development and manufacturing organization (CDMO), announced today that the U.S. Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. Nuclear Regulatory Commission Materials License for New Facility appeared first on.

Licensing 52

Licensing Licensing Manufacturing Pharmacy 52

XTalks

JANUARY 29, 2021

Biosimilars are increasingly becoming the standard of care and both have several licensed biosimilar drugs (e.g. Clinical Services International is a trusted partner of leading pharmaceutical and biotechnology companies, contract research organisations, and contract manufacturing organisations.

Clinical Trials 104

Clinical Trials Clinical Trials Production Trials 104

The Pharma Data

MARCH 16, 2021

In partnering with the Lieber Institute, Boehringer Ingelheim has in-licensed preclinical pipeline candidates, representing a first-in-class approach for targets in neuropsychiatric disorders. billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.

Development 52

Development Contract Manufacturing Licensing Licensing 52

The Pharma Data

MARCH 2, 2021

Boehringer Ingelheim and Gubra today announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the treatment of obesity. billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

The Pharma Data

DECEMBER 23, 2020

INOVIO is also assessing nonclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia.

DNA 40

DNA Vaccination Vaccine Immune Response 40

Drug Discovery World

SEPTEMBER 6, 2022

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. The Skills Demand Survey Report presents a lack of graduate life sciences apprenticeship programmes as a key barrier. Workforce .

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

The Pharma Data

NOVEMBER 15, 2020

She chairs the board of directors of Sellas Life Sciences, a publicly traded biotechnology company, chairs its nominations & governance committee, and is a member of its audit, compensation and finance committees. and international leadership positions, including Staff Vice President and Associate General Counsel.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40